Cargando…

Glucose Increases Hepatic Mitochondrial Antioxidant Enzyme Activities in Insulin Resistant Rats Following Chronic Angiotensin Receptor Blockade

Non-alcoholic fatty liver disease (NAFLD) affects up to 20% of the world’s population. Overactivation of the angiotensin receptor type 1 (AT1) contributes to metabolic dysfunction and increased oxidant production, which are associated with NAFLD and impaired hepatic lipid metabolism. Nuclear factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godoy-Lugo, Jose A., Thorwald, Max A., Mendez, Dora A., Rodriguez, Ruben, Nakano, Daisuke, Nishiyama, Akira, Ortiz, Rudy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505141/ https://www.ncbi.nlm.nih.gov/pubmed/36142809 http://dx.doi.org/10.3390/ijms231810897

Ejemplares similares

Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats
por: Thorwald, Max, et al.
Publicado: (2017)

Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats
por: Godoy-Lugo, Jose A., et al.
Publicado: (2021)

Partial Body Mass Recovery After Caloric Restriction Abolishes Improved Glucose Tolerance in Obese, Insulin Resistant Rats
por: Cornejo, Manuel A., et al.
Publicado: (2020)

Thyroid hormones and the potential for regulating glucose metabolism in cardiomyocytes during insulin resistance and T2DM
por: Mendez, Dora A., et al.
Publicado: (2021)

Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
por: Ansary, Tuba M., et al.
Publicado: (2019)

Mass recovery following caloric restriction reverses lipolysis and proteolysis, but not gluconeogenesis, in insulin resistant OLETF rats
por: Cornejo, Manuel A., et al.
Publicado: (2021)

The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies
por: Ortiz, Rudy M., et al.
Publicado: (2023)

Cardiac NF-κB Acetylation Increases While Nrf2-Related Gene Expression and Mitochondrial Activity Are Impaired during the Progression of Diabetes in UCD-T2DM Rats
por: Thorwald, Max A., et al.
Publicado: (2022)

Effect of Renin-Angiotensin System Blockade on Insulin Resistance and Inflammatory Parameters in Patients With Impaired Glucose Tolerance
por: Pscherer, Stefan, et al.
Publicado: (2010)

Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
por: Silva, Mauro G., et al.
Publicado: (2022)

Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2
por: Wang, Yong, et al.
Publicado: (2012)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”
por: Wang, Yong, et al.
Publicado: (2019)

The effectiveness and safety of angiotensin-converting enzyme inhibition or receptor blockade in vascular diseases in patients with hemodialysis
por: Liao, Kuang-Ming, et al.
Publicado: (2017)

Angiotensin-receptor blockade in acute stroke
por: Rajendran, Srijithesh P.
Publicado: (2011)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

The chronic blockade of angiotensin I-converting enzyme eliminates the sex differences of serum cytokine levels of spontaneously hypertensive rats
por: Dalpiaz, P.L.M., et al.
Publicado: (2013)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Luseogliflozin, a SGLT2 Inhibitor, Does Not Affect Glucose Uptake Kinetics in Renal Proximal Tubules of Live Mice
por: Zhang, Anqi, et al.
Publicado: (2021)

Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB
por: Zhou, Ming-Sheng, et al.
Publicado: (2015)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade
por: Han, Songling, et al.
Publicado: (2021)

Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice
por: Kittikulsuth, Wararat, et al.
Publicado: (2023)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
por: Abdul-Hay, Samer O., et al.
Publicado: (2011)

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Effect of a SGLT2 inhibitor on the systemic and intrarenal renin–angiotensin system in subtotally nephrectomized rats
por: Li, Lei, et al.
Publicado: (2017)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
por: Jones, M. R., et al.
Publicado: (2016)

Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice
por: Merino, Beatriz, et al.
Publicado: (2020)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Angiotensin blockade therapy and survival in pancreatic cancer: a population study
por: Keith, Scott W., et al.
Publicado: (2022)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lnk71rcfeuds9lkmdhqruj8btn